drugset / Trial / NCT01966718

Repository Corticotropin Injection To Treat Rheumatoid Arthritis Patients Who Have Failed Three Biologic Therapies.

NCT01966718 ↗

Phase 4 Completed 8 enrolled Arthritis Treatment Center, Maryland
NaSingle-groupOpen-labelTreatment

Summary

It is hypothesized that repository corticotropin injection in combination with other biologic agents will be able to provide relief of both rheumatoid arthritis and acute exacerbations of rheumatoid arthritis for patients with disease that had inadequately responded to biologics previously.

Timeline

Start
2013-10
Primary completion
2015-10
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Repository corticotropin injection Unknown 80 iu Subcutaneous

Indications